• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Resources
    • Resources Overview
    • Elevated Insights
    • Presentations & Publications
    • Whitepapers
  • Media
    • Media Overview
    • Press Releases
    • Featured News
  • Facilities
  • Careers
  • Contact
  • Search
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact
  • Manufacturing & Discovery Services

    Manufacturing & Discovery Services Overview

    Capabilities & Services
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
    • Investors

Presentations & Publications

// Oct 12, 2023 | Presentation

Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA

Charting a Resilient Path Forward: Future Proofing the Cell and Gene Therapy Supply Chain

View Presentation

// Oct 06, 2023 | Presentation

Cell & Gene with Outsourced Pharma - Virtual Webinar

ElevateBio Capacity Update October 2023

View Presentation

// Sep 20, 2023 | Poster

Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA

Optimization of Nuclease Treatment for Removal of Residual DNAs in Adeno-Associated Viruses

View Poster

// Sep 08, 2023 | Poster

International Society for Cell & Gene Therapy Houston, TX

Development of a Proprietary HEK293 Suspension Cell Line for Robust rAAV and LVV Production

View Poster

// Aug 17, 2023 | Poster

Genome Engineering: CRISPR Frontiers Conference Cold Spring Harbor, NY

Utilizing PAM diversity for allele-specific knockdown of mut-HTT in vivo

View Poster

// Aug 16, 2023 | Poster

15th Annual Bioprocessing Summit Boston, MA

Development and Optimization of a Scalable Affinity Purification of Adeno Associated Virus Serotype 6

View Poster

// May 19, 2023 | Poster

The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting

Optimization of Nuclease Digestion Unit Operation in a Lentiviral Vector Process for Increased Reduction of DNA Impurities

View Poster

// May 19, 2023 | Poster

The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting

Promoter Triage & PRE Triage for Gene Expression & Function Optimization

View Poster

// May 18, 2023 | Poster

The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting

A Robust and Scalable Research Grade Platform Process for AAV6 Production and Purification

View Poster

// May 17, 2023 | Poster

The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting

Upstream Optimization Paved a Straightforward Path for High Percentage of Full Capsids in AAV6

View Poster

// Apr 25, 2023 | Presentation

18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia

Allele-selective SNP editing utilizing AAV5-delivered Life Edit® nuclease and guide RNA resulting in meaningful reduction of mutant HTT protein

View Presentation

// Apr 25, 2023 | Poster

18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia

Mutant and wildtype huntingtin protein quantitation utilizing automated capillary electrophoresis

View Poster

  • Previous
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2026 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Discovery Services
  • Technologies
  • Advanced Therapies
  • Partner With Us
  • About
  • Presentations & Publications
  • Elevated Insights
  • Careers
  • Facilities
  • Contact
MENU
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact